Literature DB >> 21040781

CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population.

Jie Liu1, Junyan Li, Tao Li, Ti Wang, You Li, Zhen Zeng, Zhiqiang Li, Peng Chen, Zhiwei Hu, Lingqing Zheng, Jue Ji, He Lin, Guoyin Feng, Yongyong Shi.   

Abstract

Previous studies have reported that the cytotoxic T lymphocyte antigen-4 (CTLA-4) gene, which is related to immunological function such as T-cell regulation, is associated with psychiatric disorders. In this study, we studied the relationship between CTLA-4 and three major psychiatric disorders, schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population. We recruited 1140 schizophrenia patients, 1140 major depressive disorder patients, 1140 bipolar disorder patients, and 1140 normal controls to examine the risk conferred by 6 tag SNPs (rs231777, rs231775, rs231779, rs3087243, rs5742909, rs16840252) in the CTLA-4 gene. We found that rs231779 conferred a risk for schizophrenia (P(allele)=0.0003, P(genotype)=0.0016), major depressive disorder (P(allele)=0.0006, P(genotype)=0.0026) and bipolar disorder (P(allele)=0.0004, P(genotype)=0.0018). In addition, rs231777 and rs16840252 had a significant association with schizophrenia (rs231777: P(allele)=0.0201, rs16840252: P(allele)=0.0081, P(genotype)=0.0117), and rs231777 had significant association with bipolar disorder (rs231777: P(allele)=0.0199). However, after 10,000 permutations, only rs231779 remained significant (schizophrenia: P(allele)=0.0010, P(genotype)=0.0145, major depressive disorder: P(allele)=0.0010, P(genotype)=0.0201, bipolar disorder: P(allele)=0.0008, P(genotype)=0.0125). Our results suggest that shared common risk factors for schizophrenia, major depressive disorder and bipolar disorder exist in the CTLA-4 gene in the Chinese Han population.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040781     DOI: 10.1016/j.bbi.2010.10.024

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  9 in total

Review 1.  An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes.

Authors:  Catherine Toben; Bernhard T Baune
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-02       Impact factor: 4.147

Review 2.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

3.  Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.

Authors:  Rosemary C Bagot; Hannah M Cates; Immanuel Purushothaman; Vincent Vialou; Elizabeth A Heller; Lynn Yieh; Benoit LaBonté; Catherine J Peña; Li Shen; Gayle M Wittenberg; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2016-06-18       Impact factor: 13.382

4.  Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia.

Authors:  Dor Mohammad Kordi-Tamandani; Shahram Vaziri; Nahid Dahmardeh; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

Review 5.  Circuit-based frameworks of depressive behaviors: The role of reward circuitry and beyond.

Authors:  Daniel Knowland; Byung Kook Lim
Journal:  Pharmacol Biochem Behav       Date:  2018-01-05       Impact factor: 3.533

6.  Investigation of the Correlation between Graves' Ophthalmopathy and CTLA4 Gene Polymorphism.

Authors:  Ding-Ping Chen; Yen-Chang Chu; Ying-Hao Wen; Wei-Tzu Lin; Ai-Ling Hour; Wei-Ting Wang
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

Review 7.  Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives.

Authors:  Karrnan Pathmanandavel; Jean Starling; Russell C Dale; Fabienne Brilot
Journal:  Clin Dev Immunol       Date:  2013-08-24

8.  Altered expression of mRNA profiles in blood of early-onset schizophrenia.

Authors:  Yong Xu; Yin Yao Shugart; Guoqiang Wang; Zaohuo Cheng; Chunhui Jin; Kai Zhang; Jun Wang; Hao Yu; Weihua Yue; Fuquan Zhang; Dai Zhang
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

9.  Single-nucleotide Polymorphism of CTLA-4 (rs5742909) in Correlation with Schizophrenia Risk Factor.

Authors:  Riyadi Sumirtanurdin; James P Laksono; Haafizah Dania; Fitri N Ramadhani; Dyah A Perwitasari; Rizky Abdulah; Melisa I Barliana
Journal:  J Pharm Bioallied Sci       Date:  2019-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.